Drugs (psychoactive) - World Health Organization (WHO)
2023年8月8日 · Psychoactive drugs are substances that, when taken in or administered into one's system, affect mental processes, e.g. cognition or affect. This term and its equivalent, psychotropic drug, are the most neutral and descriptive term for the whole class of substances, licit and illicit, of interest to drug policy.
Medicines - World Health Organization (WHO)
2024年11月26日 · Today there are thousands of drugs on the market able to prevent, treat and lessen the impact of ailments that would have been fatal just a few generations ago. At the same time, antimicrobial resistance is challenging the effectiveness of many commonly used medicines in one of the most concerning threats to global health today.
WHO Drug Information - World Health Organization (WHO)
About WHO Drug Information. WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers.
Health products policy and standards - World Health Organization …
Nonproprietary names are intended for use in pharmacopoeias, labelling, product information, advertising and other promotional material, drug regulation and scientific literature, and as a basis for product names, e.g. for generics.
WHO Model Lists of Essential Medicines
2023年7月26日 · Short description: The eEML is a comprehensive, freely accessible, online database containing information on essential medicines.
Anatomical Therapeutic Chemical (ATC) Classification
Such drugs are usually only given one code and this may be a problem for users in countries where other uses are predominant. Medicinal products containing two or more active ingredients are regarded as combinations in the ATC classification system and given different ATC codes from the product with a single component (one active ingredient).
Guidelines for HIV post-exposure prophylaxis
2024年7月22日 · WHO’s updated PEP guidelines prioritize broader access to PEP, including community-based delivery and task sharing to mitigate barriers such as stigma and to ensure timely access post exposure. PEP involves administering antiretroviral (ARV) medication after potential HIV exposure to prevent infection.
Essential medicines - World Health Organization (WHO)
2024年9月25日 · WHO fact sheet on essential medicines and the WHO Essential Medicines List (EML), including key facts, impact, challenges, history, update process and WHO response.
COVID-19 Treatments - World Health Organization (WHO)
Thousands of trials investigating COVID-19 interventions have been registered or are ongoing. WHO, through its COVID-19 Solidarity Therapeutics Trial, is coordinating global efforts to find drugs and other therapies that can save lives for those with severe or critical COVID-19.
Alcohol - World Health Organization (WHO)
2024年6月28日 · Key facts. Alcohol or alcoholic beverages contain ethanol, a psychoactive and toxic substance that can cause dependence.